Breast leptomeningeal disease: a review of current practices and updates on management

[1] Le Rhun E(2017)EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours Ann Oncol 28 iv84-iv99

[2] Weller M(2006)Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG) Ann Oncol 17 935-944

[3] Brandsma D(2010)Biology and therapy of neoplastic meningitis Curr Oncol Rep 12 41-49

[4] Van den Bent M(2007)Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis Cancer 110 2640-2647

[5] de Azambuja E(2012)Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment J Neurooncol 106 303-313

[6] Henriksson R(2011)Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations Breast Cancer Res Treat 129 809-817

[7] Boulanger T(1980)Diffuse involvement of the leptomeninges by tumour: a clinical and pathological study of 63 cases Postgrad Med J 56 149-158

[8] Peters S(1983)Leptomeningeal carcinomatosis. How does cancer reach the pia-arachnoid? Cancer 51 154-160

[9] Watts C(2007)Breast cancer leptomeningeal metastasis–the role of multimodality treatment J Neurooncol 84 57-62

[10] Wick W(2011)Meningeal carcinomatosis in breast cancer: prognostic factors and outcome J Neurooncol 104 565-572

[1] Le Rhun E(2017)EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours Ann Oncol 28 iv84-iv99

[2] Weller M(2006)Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG) Ann Oncol 17 935-944

[3] Brandsma D(2010)Biology and therapy of neoplastic meningitis Curr Oncol Rep 12 41-49

[4] Van den Bent M(2007)Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis Cancer 110 2640-2647

[5] de Azambuja E(2012)Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment J Neurooncol 106 303-313

[6] Henriksson R(2011)Leptomeningeal metastases from breast cancer: intrinsic subtypes may affect unique clinical manifestations Breast Cancer Res Treat 129 809-817

[7] Boulanger T(1980)Diffuse involvement of the leptomeninges by tumour: a clinical and pathological study of 63 cases Postgrad Med J 56 149-158

[8] Peters S(1983)Leptomeningeal carcinomatosis. How does cancer reach the pia-arachnoid? Cancer 51 154-160

[9] Watts C(2007)Breast cancer leptomeningeal metastasis–the role of multimodality treatment J Neurooncol 84 57-62

[10] Wick W(2011)Meningeal carcinomatosis in breast cancer: prognostic factors and outcome J Neurooncol 104 565-572